Two Scoring Tools to Estimate the Risk of Taxane-induced Peripheral Sensory Neuropathy (PNP) in Patients Irradiated for Non-metastatic Breast Cancer

Authors: Rades, Dirk, Bartscht, Tobias, Rody, Achim, Ballegaard, Martin

Source: Rades, D, Bartscht, T, Rody, A & Ballegaard, M 2025, ' Two Scoring Tools to Estimate the Risk of Taxane-induced Peripheral Sensory Neuropathy (PNP) in Patients Irradiated for Non-metastatic Breast Cancer ', Anticancer Research, vol. 45, no. 5, pp. 2115-2121 . https://doi.org/10.21873/anticanres.17586

Subject Terms: Adult, Bridged-Ring Compounds, Peripheral Nervous System Diseases/chemically induced, Taxoids/adverse effects, Bridged-Ring Compounds/adverse effects, Peripheral Nervous System Diseases, Breast Neoplasms, Breast Neoplasms/radiotherapy, Middle Aged, Risk Assessment, Risk Factors, Humans, Female, Taxoids, Aged

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/40295044
https://curis.ku.dk/ws/files/454247185/2115.full.pdf

Chemotherapy-induced Moderate to Severe Peripheral Neuropathy in Patients Receiving Adjuvant Radiotherapy for Breast Cancer

Authors: Rades, Dirk, Bartscht, Tobias, Rody, Achim, Yu, Nathan Y, Ballegaard, Martin

Source: Rades, D, Bartscht, T, Rody, A, Yu, N Y & Ballegaard, M 2025, ' Chemotherapy-induced Moderate to Severe Peripheral Neuropathy in Patients Receiving Adjuvant Radiotherapy for Breast Cancer ', Anticancer Research, vol. 45, no. 5, pp. 2123-2135 . https://doi.org/10.21873/anticanres.17587

Subject Terms: Adult, Peripheral Nervous System Diseases/chemically induced, Incidence, Peripheral Nervous System Diseases, Breast Neoplasms, Breast Neoplasms/radiotherapy, Middle Aged, Risk Factors, Radiotherapy, Adjuvant/adverse effects, Humans, Female, Radiotherapy, Adjuvant, Aged, Retrospective Studies

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/40295075
https://curis.ku.dk/ws/files/454812953/2123.full.pdf

Neurofilament light chain as a biomarker of chemotherapy-induced peripheral neuropathy

Authors: Nanna E. Andersen, Wolfgang Boehmerle, Petra Huehnchen, Tore B. Stage

Source: Trends in Pharmacological Sciences. 45:872-879

Subject Terms: Peripheral Nervous System Diseases/chemically induced, Peripheral Nervous System Diseases, in vitro, Antineoplastic Agents, Antineoplastic Agents/adverse effects, in vivo, neurofilament light chain, Neurofilament Proteins, neurotoxicity, Neurofilament Proteins/blood, Humans, Animals, clinical studies, Biomarkers/blood, Biomarkers, chemotherapy-induced peripheral neuropathy

Access URL: https://pubmed.ncbi.nlm.nih.gov/39242335
https://portal.findresearcher.sdu.dk/da/publications/6c176c52-ca26-44a4-a56d-b386178a2e12
https://doi.org/10.1016/j.tips.2024.08.001

An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma

Authors: Christofyllakis, Konstantinos, Kaddu-Mulindwa, Dominic, Lesan, Vadim, Rixecker, Torben, Kos, Igor Age, Held, Gerhard, Regitz, Evi, Pfreundschuh, Michael, Bittenbring, Joerg Thomas, Thurner, Lorenz, Poeschel, Viola, Ziepert, Marita, Altmann, Bettina, Bewarder, Moritz

Source: Ann Hematol

Subject Terms: Adult, Male, Lymphoma, B-Cell, Genotype, Adolescent, Cell Cycle Proteins, Polymorphism, Single Nucleotide, Young Adult, Polyneuropathy, Antineoplastic Combined Chemotherapy Protocols, Humans, Genetic Predisposition to Disease, Cyclophosphamide, Aged, Aged, 80 and over, ddc:610, Research, Peripheral Nervous System Diseases, Middle Aged, Single nucleotide polymorphism, Vincristine, Aggressive lymphoma, DLBCL, Prednisone, Female, Pharmacogenomics, FOS: Medical biotechnology, Cell Cycle Proteins/genetics [MeSH], Aged, 80 and over [MeSH], Lymphoma, B-Cell/drug therapy [MeSH], Aged [MeSH], Polymorphism, Single Nucleotide [MeSH], Prednisone/adverse effects [MeSH], Cyclophosphamide/therapeutic use [MeSH], Cyclophosphamide/adverse effects [MeSH], Lymphoma, B-Cell/genetics [MeSH], Cyclophosphamide/administration, Male [MeSH], Prednisone/therapeutic use [MeSH], Peripheral Nervous System Diseases/chemically induced [MeSH], Genetic Predisposition to Disease [MeSH], Adolescent [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Peripheral Nervous System Diseases/genetics [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Prednisone/administration, Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Young Adult [MeSH], Genotype [MeSH], Vincristine/adverse effects [MeSH], Microtubule-Associated Proteins/genetics [MeSH], Microtubule-Associated Proteins

Access URL: https://pubmed.ncbi.nlm.nih.gov/39227453
https://repository.publisso.de/resource/frl:6523196

The course of chemotherapy-induced peripheral neuropathy (CIPN) in hematological patients treated with vincristine, bortezomib, or lenalidomide: the NOVIT study: the NOVIT study

Authors: Eva Futtrup Maksten, Carsten Dahl Mørch, Lasse Hjort Jakobsen, Kristian Hay Kragholm, Pernille From Blindum, Mikkel Runason Simonsen, Niels Ejskjaer, Karen Dybkær, Henrik Gregersen, Jakob Madsen, Tarec C. El-Galaly, Marianne Tang Severinsen

Source: Support Care Cancer
Maksten, E F, Mørch, C D, Jakobsen, L H, Kragholm, K H, Blindum, P F, Simonsen, M R, Ejskjaer, N, Dybkær, K, Gregersen, H, Madsen, J, El-Galaly, T C & Severinsen, M T 2025, 'The course of chemotherapy-induced peripheral neuropathy (CIPN) in hematological patients treated with vincristine, bortezomib, or lenalidomide: the NOVIT study', Supportive Care in Cancer, vol. 33, no. 3, 225. https://doi.org/10.1007/s00520-025-09282-3

Subject Terms: Male, Adult, Numbness, Vincristine/adverse effects, Lymphoma, Peripheral Nervous System Diseases/chemically induced, Antineoplastic Agents, Survivorship, Hematologic Neoplasms/drug therapy, Bortezomib, Multiple myeloma, Antineoplastic Combined Chemotherapy Protocols, Lenalidomide/administration & dosage, Tingling, Humans, Longitudinal Studies, Lenalidomide, Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Research, Peripheral Nervous System Diseases, Antineoplastic Agents/adverse effects, Middle Aged, Vincristine, Hematologic Neoplasms, Female, Bortezomib/adverse effects

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/40011273
http://www.scopus.com/inward/record.url?scp=85218734211&partnerID=8YFLogxK
https://vbn.aau.dk/ws/files/768536239/s00520-025-09282-3.pdf
https://vbn.aau.dk/da/publications/cb37d27b-cd7e-47c8-8b45-e914f34be36e
https://doi.org/10.1007/s00520-025-09282-3
https://portal.findresearcher.sdu.dk/da/publications/bedcb2f2-adb6-4de8-a18b-badf1f136e60
https://doi.org/10.1007/s00520-025-09282-3

Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy

Authors: Florence van Hunsel, Joep Scholl, Misha Vrolijk, Corine Ekhart

Source: Pharmacoepidemiol Drug Saf

Subject Terms: Male, Adult, Peripheral Nervous System Diseases/chemically induced, Netherlands/epidemiology, Dose-Response Relationship, Humans, Adverse Drug Reaction Reporting Systems, Netherlands, Aged, vitamin B6 supplementation, Dose-Response Relationship, Drug, Brief Report, Peripheral Nervous System Diseases, Vitamin B 6/administration & dosage, Middle Aged, Adverse Drug Reaction Reporting Systems/statistics & numerical data, Vitamin B 6, pharmacovigilance, Dietary Supplements, neuropathy, spontaneous reporting system, Female, impact analysis, Dietary Supplements/adverse effects, Drug, Nervous System Diseases, Vitamin B 6 Deficiency

Access URL: https://pubmed.ncbi.nlm.nih.gov/39888171
https://research.rug.nl/en/publications/97f299d8-12bb-4039-8870-753c4415b229
https://hdl.handle.net/11370/97f299d8-12bb-4039-8870-753c4415b229
https://doi.org/10.1002/pds.70108
https://cris.maastrichtuniversity.nl/en/publications/34cadcb0-de3c-4a03-872c-f4016f651985
https://doi.org/10.1002/pds.70108

Neurofilament light chain as a biomarker of axonal damage in sensory neurons and paclitaxel-induced peripheral neuropathy in patients with ovarian cancer

Authors: Christina Mortensen, Karina Dahl Steffensen, Emma Simonsen, Kamille Herskind, Jonna Skov Madsen, Dorte Aalund Olsen, Ditte Bork Iversen, Troels Korshøj Bergmann, Anton Pottegård, Tore Bjerregaard Stage

Source: Pain. 164:1502-1511

Subject Terms: Ovarian Neoplasms, Paclitaxel, Sensory Receptor Cells, Peripheral Nervous System Diseases/chemically induced, Induced Pluripotent Stem Cells, Intermediate Filaments, Ovarian Neoplasms/drug therapy, Peripheral Nervous System Diseases, 3. Good health, Carboplatin, 03 medical and health sciences, Carboplatin/adverse effects, 0302 clinical medicine, Neurofilament Proteins, Paclitaxel/adverse effects, Quality of Life, Humans, Female, Biomarkers, Retrospective Studies

Access URL: https://pubmed.ncbi.nlm.nih.gov/36508173

Mindfulness is associated with severity of peripheral neuropathy and related patient-reported outcomes among colorectal cancer patients

Authors: Bonhof, Cynthia S, van de Poll-Franse, Lonneke V, de Hingh, Ignace H, Vreugdenhil, Gerard, Mols, Floortje

Source: Support Care Cancer

Subject Terms: Peripheral Nervous System Diseases/chemically induced, Research, Peripheral Nervous System Diseases, Colorectal Neoplasms/drug therapy, Netherlands/epidemiology, Antineoplastic Agents, Antineoplastic Agents/adverse effects, Fatigue/epidemiology, Severity of Illness Index, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Humans, Patient Reported Outcome Measures, Colorectal Neoplasms, Mindfulness, Fatigue, Neoplasm Staging, Netherlands

Access URL: https://pubmed.ncbi.nlm.nih.gov/36030458
https://research.tilburguniversity.edu/en/publications/af64e5a0-0f57-4d0c-85a3-9f8033ccc16e
https://doi.org/10.1007/s00520-022-07340-8
https://cris.maastrichtuniversity.nl/en/publications/9dc807c0-bcda-4dcf-9ab8-1821fba0902d
https://doi.org/10.1007/s00520-022-07340-8

Neuropathy and pain after breast cancer treatment: a prospective observational study: A prospective observational study

Authors: Bennedsgaard, K, Grosen, K, Attal, N, Bouhassira, D, Crombez, G, Jensen, TS, Bennett, DL, Ventzel, L, Andersen, IS, Finnerup, NB

Contributors: Aarhus University Aarhus, Aarhus University Hospital, VIA University College, Physiopathologie et Pharmacologie Clinique de la Douleur (LPPD), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Ambroise Paré AP-HP, Universiteit Gent = Ghent University = Université de Gand (UGENT), University of Oxford, University of Southern Denmark (SDU), Eli Lilly and Company, AstraZeneca, Novartis Pharma, Horizon 2020 Framework Programme, H2020: 633491, Biotechnology and Biological Sciences Research Council, BBSRC, Innovative Medicines Initiative, IMI, Research funding: This work was supported by the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No 633491 (DOLORisk). The funding source had no involvement in the conduct of the study, manuscript preparation, or decision to publish., Competing interests: The authors declare no conflict of interest. Outside the submitted work, DB has acted as consultant for Grünenthal, Novartis, Bayer, Air Liquide, Vertex, and Angelini. Outside the submitted work, DLB has acted as a consultant on behalf of Oxford Innovation for Amgen, Bristows, LatigoBio, GSK, Ionis, Lilly, Olipass, Orion, Regeneron and Theranexus over the last 2 years. He has received research funding from Lilly and has received an industrial partnership grant from the BBSRC and AstraZeneca outside the submitted work. NA has received honoraria from Pfizer, Grunenthal, Novartis, Upsa, Merz Pharma, Air Liquide, and Biogen outside the submitted work. NBF reports personal fees from Almirall, NeuroPN, Novartis Pharma, and Vertex and has undertaken consultancy work for Aarhus University with remunerated work for Biogen, Merz, and Confo Therapeutics, outside the submitted work and has received a grant from IMI2PainCare an EU IMI 2 (Innovative Medicines Initiative) public-private consortium and the companies involved are: Grünenthal, Bayer, Eli Lilly, Esteve, and Teva, outside the submitted work., European Project: 633491,H2020,H2020-PHC-2014-two-stage,DOLORisk(2015)

Source: SCANDINAVIAN JOURNAL OF PAIN
Bennedsgaard, K, Grosen, K, Attal, N, Bouhassira, D, Crombez, G, Jensen, T S, Bennett, D L, Ventzel, L, Andersen, I S & Finnerup, N B 2023, 'Neuropathy and pain after breast cancer treatment : A prospective observational study', Scandinavian Journal of Pain, vol. 23, no. 1, pp. 49-58. https://doi.org/10.1515/sjpain-2022-0017

Subject Terms: Breast Neoplasms/complications, Peripheral Nervous System Diseases/chemically induced, QUESTIONNAIRE, Pain, [SDV.CAN]Life Sciences [q-bio]/Cancer, Breast Neoplasms, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery, chemotherapy, THERAPY, 03 medical and health sciences, breast cancer, 0302 clinical medicine, RESIDUAL LIMB PAIN, QUALITY-OF-LIFE, Surveys and Questionnaires, Medicine and Health Sciences, Humans, Prospective Studies, CIPN, Pain/diagnosis, SURVIVORS, COMPLICATIONS, lumpectomy, PERSISTENCE, mastectomy, Peripheral Nervous System Diseases, PREVALENCE, AMPUTEES, 3. Good health, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Female, polyneuropathy, PERIPHERAL NEUROPATHY

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/35636394
https://ora.ox.ac.uk/objects/uuid:0c2eb944-599c-47de-a407-853a3162f32e
https://doi.org/10.1515/sjpain-2022-0017
https://portal.findresearcher.sdu.dk/da/publications/a8fd6ab4-dcea-440d-8bda-8367ffb60fed
https://doi.org/10.1515/sjpain-2022-0017
https://biblio.ugent.be/publication/01GT90T5KRGB4E2PHMAQGC0JFB
http://hdl.handle.net/1854/LU-01GT90T5KRGB4E2PHMAQGC0JFB
http://doi.org/10.1515/sjpain-2022-0017
https://biblio.ugent.be/publication/01GT90T5KRGB4E2PHMAQGC0JFB/file/01GT911H9NMT6K4WKV5WXCP02Z
http://www.scopus.com/inward/record.url?scp=85131683071&partnerID=8YFLogxK
https://pure.au.dk/portal/en/publications/388aecae-31df-4ce7-a7d5-e3d95b3f0a5a
https://doi.org/10.1515/sjpain-2022-0017

Study protocol: fish oil supplement in prevention of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer patients – a randomized controlled trial. (OxaNeuro): fish oil supplement in prevention of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer patients – a randomized controlled trial. (OxaNeuro)

Authors: Gehr, Nina Lykkegaard, Karlsson, Páll, Timm, Signe, Christensen, Signe, Hvid, Christian Andreas, Peric, Jana, Hansen, Torben Frøstrup, Lauritzen, Lotte, Finnerup, Nanna Brix, Ventzel, Lise

Source: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Gehr, N L, Karlsson, P, Timm, S, Christensen, S, Hvid, C A, Peric, J, Hansen, T F, Lauritzen, L, Finnerup, N B & Ventzel, L 2024, 'Study protocol: fish oil supplement in prevention of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer patients – a randomized controlled trial. (OxaNeuro)', BMC Cancer, vol. 24, no. 1, 168 . https://doi.org/10.1186/s12885-024-11856-z
Gehr, N L, Karlsson, P, Timm, S, Christensen, S, Hvid, C A, Peric, J, Hansen, T F, Lauritzen, L, Finnerup, N B & Ventzel, L 2024, ' Study protocol : fish oil supplement in prevention of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer patients – a randomized controlled trial. (OxaNeuro) ', BMC Cancer, vol. 24, no. 1, 168 . https://doi.org/10.1186/s12885-024-11856-z
Gehr, N L, Karlsson, P, Timm, S, Christensen, S, Hvid, C A, Peric, J, Hansen, T F, Lauritzen, L, Finnerup, N B & Ventzel, L 2024, 'Study protocol : fish oil supplement in prevention of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer patients-a randomized controlled trial. (OxaNeuro)', BMC Cancer, vol. 24, pp. 168. https://doi.org/10.1186/s12885-024-11856-z

Subject Terms: Quality of life, Neurofilament light, Peripheral Nervous System Diseases/chemically induced, Fish oil, Oxaliplatin/adverse effects, Study Protocol, Fish Oils, Adjuvants, Immunologic, Omega-3 fatty acids, Humans, Multicenter Studies as Topic, Adjuvants, RC254-282, Randomized Controlled Trials as Topic, Inflammation, Chemotherapy-induced peripheral neuropathy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Peripheral Nervous System Diseases, Colorectal Neoplasms/drug therapy, Adjuvants, Immunologic/therapeutic use, Colorectal cancer, 3. Good health, Oxaliplatin, Randomized controlled trial, Fish Oils/therapeutic use, Dietary Supplements, Quality of Life, Colorectal Neoplasms, Specialized proresolving mediators, Immunologic/therapeutic use

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38308227
https://doaj.org/article/207e261681104d0d8d0a91e3e2e700b1
http://www.scopus.com/inward/record.url?scp=85183807222&partnerID=8YFLogxK
https://vbn.aau.dk/ws/files/675388836/Gehr_et_al._2024_._Study_protocol_-_fish_oil_supplement_in_prevention_of_oxaliplatin-induced_peripheral_neuropathy_in_adjuvant_colorectal_cancer_patients_-_a_randomized_controlled_trial._OxaNeuro_.pdf
https://doi.org/10.1186/s12885-024-11856-z
https://vbn.aau.dk/da/publications/984a6aec-e05a-4508-810b-ae29538507e0
https://curis.ku.dk/ws/files/387218138/s12885_024_11856_z.pdf
https://portal.findresearcher.sdu.dk/da/publications/d8343bc2-0368-4eef-8627-c8d867112e6a
https://doi.org/10.1186/s12885-024-11856-z
https://pure.au.dk/portal/en/publications/3cdd2d3a-f41d-41aa-a89f-960b6084ed4e
http://www.scopus.com/inward/record.url?scp=85183807222&partnerID=8YFLogxK
https://doi.org/10.1186/s12885-024-11856-z

Symptoms of pre-treatment anxiety are associated with the development of chronic peripheral neuropathy among colorectal cancer patients

Authors: Bonhof, C.S., van de Graaf, D.L., Wasowicz, D.K., Vreugdenhil, G., Mols, F.

Source: Support Care Cancer

Subject Terms: Peripheral Nervous System Diseases/chemically induced, Anxiety/etiology, Peripheral Nervous System Diseases, Anxiety, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Colorectal Neoplasms/complications, SDG 3 - Good Health and Well-being, Surveys and Questionnaires, Quality of Life, Humans, Original Article, Colorectal Neoplasms

Access URL: https://pubmed.ncbi.nlm.nih.gov/35303166
https://research.tilburguniversity.edu/en/publications/028ebca9-deab-42c0-b7eb-828dc8761002
https://doi.org/10.1007/s00520-022-06971-1

Neurophysiologic assessment of small fibre damage in chemotherapy-induced peripheral neuropathy

Authors: Lise Ventzel, Hatice Tankisi, Nanna B. Finnerup, Baris Isak, Anders Fuglsang-Frederiksen, Kirsten Pugdahl

Source: Isak, B, Tankisi, H, Pugdahl, K, Ventzel, L, Finnerup, N B & Fuglsang-Frederiksen, A 2021, 'Neurophysiologic assessment of small fibre damage in chemotherapy-induced peripheral neuropathy', Clinical Neurophysiology, vol. 132, no. 8, pp. 1947-1956. https://doi.org/10.1016/j.clinph.2021.02.406

Subject Terms: Adult, Male, 0301 basic medicine, Electromyography/drug effects, Peripheral Nervous System Diseases/chemically induced, Laser, Laser-Evoked Potentials/drug effects, Quantitative sensory testing, Small fibre, Antineoplastic Agents, Docetaxel, Oxaliplatin/adverse effects, 03 medical and health sciences, Laser-Evoked Potentials, Nerve Fibers, 0302 clinical medicine, Chemotherapy, Humans, Docetaxel/adverse effects, Aged, Electromyography, Peripheral Nervous System Diseases, Antineoplastic Agents/adverse effects, Middle Aged, Oxaliplatin, Cutaneous silent period, Cross-Sectional Studies, Female, Nerve Fibers/drug effects

Access URL: https://pubmed.ncbi.nlm.nih.gov/34034962
https://www.sciencedirect.com/science/article/abs/pii/S1388245721005277
https://avesis.marmara.edu.tr/yayin/8feeccf0-424d-4bf3-8327-92d3824b9f67/neurophysiologic-assessment-of-small-fibre-damage-in-chemotherapy-induced-peripheral-neuropathy
https://pubmed.ncbi.nlm.nih.gov/34034962/
https://europepmc.org/article/MED/34034962
https://www.ncbi.nlm.nih.gov/pubmed/34034962
https://portal.findresearcher.sdu.dk/da/publications/d35b448a-2244-4158-becd-fd161a003af6
https://doi.org/10.1016/j.clinph.2021.02.406
https://pure.au.dk/portal/en/publications/47afdfb5-82ce-4caf-a062-afbb412d9d03
http://www.scopus.com/inward/record.url?scp=85106634193&partnerID=8YFLogxK
https://doi.org/10.1016/j.clinph.2021.02.406

Preventive effect of sensorimotor exercise and resistance training on chemotherapy-induced peripheral neuropathy: a randomised-controlled trial

Authors: Wolfgang Wick, Karen Steindorf, Andreas Schneeweiss, Jana Müller, Georg Martin Haag, Markus Weiler, Joachim Wiskemann

Source: Br J Cancer

Subject Terms: Adult, Male, Peripheral Nervous System Diseases, Antineoplastic Agents, Resistance Training, Middle Aged, Article, 3. Good health, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Quality of Life, Humans, Patient Compliance, Female [MeSH], Peripheral Nervous System Diseases/prevention, Antineoplastic Agents/adverse effects [MeSH], Aged [MeSH], Neurological manifestations, Adult [MeSH], Physical Therapy Modalities/psychology [MeSH], Resistance Training/methods [MeSH], Humans [MeSH], Breast cancer, Lifestyle modification, Treatment Outcome [MeSH], Quality of Life/psychology [MeSH], Middle Aged [MeSH], Randomized controlled trials, Quality of life, Male [MeSH], Patient Compliance/statistics, Peripheral Nervous System Diseases/chemically induced [MeSH], Female, Physical Therapy Modalities, Aged

Access URL: https://www.nature.com/articles/s41416-021-01471-1.pdf
https://pubmed.ncbi.nlm.nih.gov/34226683
https://pubmed.ncbi.nlm.nih.gov/34226683/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476560
https://www.nature.com/articles/s41416-021-01471-1
https://www.nature.com/articles/s41416-021-01471-1.pdf
https://repository.publisso.de/resource/frl:6442880

Longitudinal Associations of Sedentary Behavior and Physical Activity with Quality of Life in Colorectal Cancer Survivors

Authors: Kenkhuis, Marlou Floor, VAN Roekel, Eline H., Breedveld-Peters, José J.L., Breukink, Stéphanie O., Janssen-Heijnen, Maryska L.G., Keulen, Eric T.P., VAN Duijnhoven, Fränzel J.B., Mols, Floortje, Weijenberg, Matty P., Bours, Martijn J.L.

Source: Med Sci Sports Exerc

Subject Terms: Male, Epidemiology, Peripheral Nervous System Diseases/chemically induced, BIOMARKERS, EUROPEAN-ORGANIZATION, QUESTIONNAIRE, Antineoplastic Agents, GUIDELINES, FATIGUE, CLASSIFICATION, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Cancer Survivors, Cancer Survivors/psychology, Life Science, Humans, Longitudinal Studies, Prospective Studies, Exercise, COLORECTAL CANCER SURVIVORSHIP, Fatigue, Aged, HEALTH-RELATED QUALITY OF LIFE, CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY, INDUCED PERIPHERAL NEUROPATHY, SEDENTARY BEHAVIOR, Peripheral Nervous System Diseases, Antineoplastic Agents/adverse effects, CHEMOTHERAPY, Middle Aged, TIME, 3. Good health, Colorectal Neoplasms/complications, Quality of Life, Female, HEALTH, PHYSICAL ACTIVITY, Sedentary Behavior, Fatigue/etiology, Colorectal Neoplasms

Access URL: https://journals.lww.com/acsm-msse/Fulltext/2021/11000/Longitudinal_Associations_of_Sedentary_Behavior.10.aspx
https://pubmed.ncbi.nlm.nih.gov/34033619
https://cris.maastrichtuniversity.nl/en/publications/65d3c91d-1ce0-47f5-930c-e1d3dfa229eb
https://doi.org/10.1249/MSS.0000000000002703
https://www.ncbi.nlm.nih.gov/pubmed/34033619
https://europepmc.org/article/med/34033619
https://pubmed.ncbi.nlm.nih.gov/34033619/
https://research.wur.nl/en/publications/longitudinal-associations-of-sedentary-behavior-and-physical-acti
https://doi.org/10.1249/mss.0000000000002703

The prevalence, distribution and impact of peripheral neuropathy among Danish patients with cancer – a population-based cross-sectional study

Authors: Jørn Herrstedt, Sebastian Werngreen Nielsen, Lise Eckhoff, Christina H Ruhlmann, Susanne Oksbjerg Dalton

Source: Nielsen, S W, Eckhoff, L, Ruhlmann, C H B, Herrstedt, J & Dalton, S O 2022, ' The prevalence, distribution and impact of peripheral neuropathy among Danish patients with cancer–a population-based cross-sectional study ', Acta Oncologica, vol. 61, no. 3, pp. 363-370 . https://doi.org/10.1080/0284186X.2021.2007283

Subject Terms: Adult, peripheral neuropathy, Peripheral Nervous System Diseases/chemically induced, Denmark, Peripheral Nervous System Diseases, Denmark/epidemiology, cancer treatment, Neoplasms/drug therapy, 3. Good health, 03 medical and health sciences, Cross-Sectional Studies, 0302 clinical medicine, Neurological complications, Neoplasms, Surveys and Questionnaires, adverse effects, Prevalence, Quality of Life, Humans, Female, chemotherapy-induced peripheral neuropathy

File Description: application/pdf

Access URL: https://www.researchsquare.com/article/rs-375423/v1.pdf?c=1638333966000
https://www.researchsquare.com/article/rs-375423/v1.pdf?c=1621599294000
https://pubmed.ncbi.nlm.nih.gov/34846991
https://www.researchsquare.com/article/rs-375423/v1
https://www.researchsquare.com/article/rs-375423/v1.pdf?c=1631895803000
https://europepmc.org/article/PPR/PPR315827
https://curis.ku.dk/ws/files/288190348/7d1694a6_111b_49e7_9a36_ce345b2cbc1d.pdf
https://portal.findresearcher.sdu.dk/da/publications/2b71954e-e737-44c2-83ad-6be2068a2157
https://doi.org/10.1080/0284186X.2021.2007283
https://portal.findresearcher.sdu.dk/da/publications/2b71954e-e737-44c2-83ad-6be2068a2157

Preliminary Insights into JWH182: a Synthetic Cannabinoid’s Neuroprotective Role Against Paclitaxel-Induced Neuronal Toxicity

Authors: Mălina Maria Cernătescu, Ioana Creangă-Murariu, Bogdan Ionel Tamba

Source: International Journal of Medical Students, Vol 11 (2023)

Subject Terms: Cannabinoids, Paclitaxel, Antineoplastic Agents / Toxicity, Peripheral Nervous System Diseases / Chemically Induced, Peripheral Nervous System Diseases / Therapy, Medicine (General), R5-920, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: http://ijms.info/IJMS/article/view/2236; https://doaj.org/toc/2076-6327

Access URL: https://doaj.org/article/972d1efedaa64c1aade3ace24a47a6c7

Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy

Authors: de Jong, Corine, Herder, Gerarda J M, van Haarlem, Simone W A, van der Meer, Femke S, van Lindert, Anne S R, Ten Heuvel, Alexandra, Brouwer, Jan, Egberts, Toine C G, Deneer, Vera H M

Contributors: Apotheek Onderzoek, Cancer, Arts Assistenten Longziekten, Longziekten, Infection & Immunity, Apotheek Klinische Farmacie

Subject Terms: Carcinoma, Non-Small-Cell Lung/drug therapy, Follow-Up Studies, Humans, Lung Neoplasms/drug therapy, Peripheral Nervous System Diseases/chemically induced, Platinum/adverse effects, Prospective Studies, chemotherapy-induced peripheral neuropathy (CIPN), chemotherapy-induced toxicity, platinum-based chemotherapy, neurotoxicity, non-small cell lung cancer (NSCLC), Genetics(clinical), Genetics, Multicenter Study, Journal Article

File Description: application/pdf

Relation: https://dspace.library.uu.nl/handle/1874/448660

Availability: https://dspace.library.uu.nl/handle/1874/448660

Le renouveau du thalidomide. Un vieux medicament aux nouvelles indications. [The revival of thalidomide: an old drug with new indications]

Authors: Laffitte, E.

Subject Terms: Angiogenesis Inhibitors/pharmacology/*therapeutic use Drug Eruptions Humans Leprostatic Agents/pharmacology/*therapeutic use Peripheral Nervous System Diseases/chemically induced Skin Diseases/drug therapy Teratogens/pharmacology Thalidomide/pharmacology/*therapeutic use Thrombosis/chemically induced

Relation: Revue du praticien; https://iris.unil.ch/handle/iris/59949; serval:BIB_313578B2381C

Availability: https://iris.unil.ch/handle/iris/59949

Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study

Authors: Rutschmann, O. T., Vernazza, P. L., Bucher, H. C., Opravil, M., Ledergerber, B., Telenti, A., Malinverni, R., Bernasconi, E., Fagard, C., Leduc, D., Perrin, L., Hirschel, B.

Subject Terms: Anti-HIV Agents/adverse effects/*therapeutic use Diarrhea/chemically induced Didanosine/adverse effects/*therapeutic use Drug Therapy, Combination Enzyme Inhibitors/adverse effects/*therapeutic use Follow-Up Studies HIV Infections/*drug therapy *Hiv-1 Humans Hydroxyurea/adverse effects/*therapeutic use Nausea/chemically induced Peripheral Nervous System Diseases/chemically induced Stavudine/adverse effects/*therapeutic use

Relation: AIDS; https://iris.unil.ch/handle/iris/226872; serval:BIB_90E4BAC0C751; 000089981100011

Availability: https://iris.unil.ch/handle/iris/226872
https://doi.org/10.1097/00002030-200009290-00011

Anti-TNF alpha medications and neuropathy.

Authors: Tsouni, P., Bill, O., Truffert, A., Liaudat, C., Ochsner, F., Steck, A.J., Kuntzer, T.

Subject Terms: Adalimumab/adverse effects, Adalimumab/therapeutic use, Adult, Aged, Autoimmune Diseases/drug therapy, Electrodiagnosis, Etanercept/adverse effects, Etanercept/therapeutic use, Female, Humans, Infliximab/adverse effects, Infliximab/therapeutic use, Male, Middle Aged, Neural Conduction/physiology, Peripheral Nervous System Diseases/chemically induced, Peripheral Nervous System Diseases/diagnosis, Rheumatic Diseases/drug therapy, Tumor Necrosis Factor-alpha/antagonists & inhibitors

Relation: Journal of the Peripheral Nervous System; https://iris.unil.ch/handle/iris/213006; serval:BIB_DA553F1DD0E2; 000368136000007

Availability: https://iris.unil.ch/handle/iris/213006
https://doi.org/10.1111/jns.12147